FDA 503B sterile compounding and pre-filled syringe manufacturer
SCA Pharma operates two FDA-regulated sterile manufacturing facilities (Windsor, CT and Little Rock, AR) producing admixtures and pre-filled syringes for hospital systems. The tech stack—Snowflake, Databricks, Python, Power BI—signals data infrastructure investment atypical for traditional pharma manufacturing, suggesting analytics-driven quality and compliance operations. Manufacturing-heavy hiring (9 of 16 open roles) aligns with active scale-up and product launch projects, while compliance pain points (FDA/cGMP alignment, supplier regulation tracking) map to their regulatory environment.
SCA Pharma is a privately held FDA 503B outsourcing facility founded in 2011, headquartered in Little Rock, Arkansas with a larger manufacturing footprint in Windsor, Connecticut (90,000+ sq ft of sterile compounding lab). The company manufactures sterile admixtures and pre-filled syringes for hospital and health-system customers nationwide. Current operational footprint spans 501–1,000 employees distributed across two facilities and a national sales team. Active projects center on scaling lab formulations to commercial production, launching products for key accounts, and strengthening supplier qualification programs.
Two FDA-regulated sterile compounding facilities: Windsor, CT (90,000+ sq ft) and Little Rock, AR (17,000 sq ft), employing 500+ staff across both sites plus sales representatives nationwide.
Snowflake, Azure Data Factory, Databricks, Python, Snowpark, and Power BI for data infrastructure; Jira and Confluence for collaboration; GitHub for version control.
Other companies in the same industry, closest in size